Get started
Author

Gaku Oshikawa

Observed names: G Oshikawa, G. Oshikawa, GAKU OSHIKAWA
OpenAlex ID: A5032874540
FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia
2015 · Ayako Nogami, Gaku Oshikawa, et al. · Oncotarget · 69
PDF
Post‐transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high‐risk acute myeloid leukaemia
2014 · Gaku Oshikawa, Kazuhiko Kakihana, et al. · British Journal of Haematology · 61
PDF
c-Cbl and Cbl-b Ligases Mediate 17-Allylaminodemethoxygeldanamycin-induced Degradation of Autophosphorylated Flt3 Kinase with Internal Tandem Duplication through the Ubiquitin Proteasome Pathway
2011 · Gaku Oshikawa, Toshikage Nagao, et al. · Journal of Biological Chemistry · 46
PDF
Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway
2010 · Tetsuya Kurosu, Nan Wu, et al. · APOPTOSIS · 45
Inhibition of the PI3K/Akt/GSK3 Pathway Downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD Downregulates DNA Damage-Induced Chk1 Activation as Well as G2/M Arrest and Prominently Enhances Induction of Apoptosis
2013 · Tetsuya Kurosu, Toshikage Nagao, et al. · PLoS ONE · 43
PDF
Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2
2018 · Shinya Ishida, Hiroki Akiyama, et al. · Oncotarget · 27
Proliferation and Survival Signaling from Both Jak2-V617F and Lyn Involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 Cell Line Newly Established from Acute Myeloid Leukemia Transformed from Polycythemia Vera
2014 · Toshikage Nagao, Tetsuya Kurosu, et al. · PLoS ONE · 25
PDF
Bortezomib-induced Posterior Reversible Encephalopathy Syndrome in a Patient with Newly Diagnosed Multiple Myeloma
2013 · Gaku Oshikawa, Akira Kojima, et al. · Internal Medicine · 23
PDF
Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation
2014 · Y. Umezawa, K. Kakihana, et al. · Transplant Infectious Disease · 19
A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival
2015 · T Nagao, G Oshikawa, et al. · Blood Cancer Journal · 18
PDF
Acute promyelocytic leukemia presenting as recurrent spinal myeloid sarcomas 3 years before developing leukemia: A case report with review of literature
2019 · Tomoko Yamashita, Akihiko Nishijima, et al. · Clinical Case Reports · 16
PDF
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report
2017 · Keisuke Tanaka, Gaku Oshikawa, et al. · Oncology Letters · 16
PDF
DNA Damage Stress and Inhibition of Jak2-V617F Cause Its Degradation and Synergistically Induce Apoptosis through Activation of GSK3β
2011 · Toshikage Nagao, Gaku Oshikawa, et al. · PLoS ONE · 16
PDF
Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation
2010 · Gaku Oshikawa, Tetsuya Kurosu, et al. · Cancer Genetics and Cytogenetics · 14
Extranodal NK/T cell lymphoma, nasal type, of the small intestine diagnosed by double-balloon endoscopy
2009 · Shihoko Wakabayashi, Ayako Arai, et al. · International Journal of Hematology · 14
Molecular mechanisms for enhancement of stromal cell-derived factor 1–induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1)
2017 · Yoshihiro Umezawa, Hiroki Akiyama, et al. · Journal of Biological Chemistry · 11
PDF
Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study
2025 · Jong Wook Lee, Jun Ho Jang, et al. · British Journal of Haematology · 10
Impact of prior azacitidine on the outcome of allogeneic hematopoietic transplantation for myelodysplastic syndrome
2015 · Gaku Oshikawa, Kousuke Yoshioka, et al. · Pathology & Oncology Research · 10
Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study
2023 · Chikashi Yoshida, Hiroki Yamaguchi, et al. · International Journal of Hematology · 9
PDF
PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells
2012 · NAN WU, TETSUYA KUROSU, et al. · International Journal of Oncology · 9
PDF
Clinical Outcome of Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL): Experience From a Single Institution
2013 · Noriko Doki, Kazuteru Ohashi, et al. · Pathology & Oncology Research · 7
[Primary multifocal osseous Hodgkin lymphoma].
2009 · Gaku Oshikawa, Ayako Arai, et al. · PubMed · 7
Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities
2023 · Gaku Oshikawa, Koji Sasaki · Cancers · 6
PDF
[Bortezomib-induced tumor lysis syndrome with a remarkable elevation of LDH in a case of relapsed and therapy-resistant multiple myeloma].
2006 · Ayako Arai, Gaku Oshikawa, et al. · PubMed · 5
Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia
2014 · Shuntaro Ikegawa, Noriko Doki, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Works count: 55
Citation count: 557
H-index: 14
I10-index: 18
Year
Topic
Type